Showing results (191-200 of 303) with videos related to

Sort By:
Pageof 31
Cell|November 19, 1993
Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouseW F Dietrich, E S Lander, J S Smith, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
A phase I/II study of 4'-O-tetrahydropyranyl-doxorubicin, 5-fluorouracil, and high-dose leucovorin as first-line therapy in advanced breast cancer patientsH Stöger, T Bauernhofer, M Schmid, et al.
Journal of the American Veterinary Medical Association|July 3, 2008
Pituitary-adrenal function in dogs with acute critical illnessLinda G Martin, Reid P Groman, Daniel J Fletcher, et al.
Trends in Biotechnology|December 9, 2014
Microbial lipid-based lignocellulosic biorefinery: feasibility and challengesMingjie Jin, Patricia J Slininger, Bruce S Dien, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Weekly 5-fluorouracil and high-dose folinic acid in combination with epidoxorubicin as first-line therapy in advanced breast cancer: a phase II studyH Stöger, T Bauernhofer, A K Kasparek, et al.
Science (New York, N.Y.)|May 1, 1992
Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC geneL K Su, K W Kinzler, B Vogelstein, et al.
Oncology|November 1, 1994
A phase II trial of weekly high-dose folinic acid and 5-fluorouracil in combination with epirubicin as salvage chemotherapy in advanced breast cancerH Stöger, M Schmid, T Bauernhofer, et al.
Cancer Research|March 1, 1997
Intestinal neoplasia in the ApcMin mouse: independence from the microbial and natural killer (beige locus) statusW F Dove, L Clipson, K A Gould, et al.
European Journal of Cancer (Oxford, England : 1990)|August 17, 1999
Biochemical modulation of 5-fluorouracil by leucovorin with or without interferon-alpha-2c in patients with advanced colorectal cancer: final results of a randomised phase III studyH Hausmaninger, R Moser, H Samonigg, et al.
Cancer Research|December 18, 2003
Up-regulation of fibroblast growth factor-binding protein, by beta-catenin during colon carcinogenesisRanjan Ray, Rafael Cabal-Manzano, Amy R Moser, et al.
Pageof 31